Emmac Life Sciences, a European vertically integrated cannabis producer, said it raised 15 million pounds ($20 million) via an issue of convertible loan notes. The Dec. 16 issue “saw strong support from existing shareholders, with Measure 8 Ventu…
Author: Amy Hansen
Colombian agency recommends allowing cannabis flower exports
The Colombian government may reconsider its ban on medical cannabis flower exports for commercial purposes. A recent letter by the Superintendency of Industry and Commerce (SIC) – a government agency that promotes fair business practices – …
Cannabis producer Clever Leaves starts trading in Nasdaq
Clever Leaves Holdings will began trading on the Nasdaq on Friday, the company announced before the market opened, the first cannabis producer with its main operations in Colombia to trade on a large American stock exchange. Clever Leaves Holdings is t…
Insurance-covered medical cannabis reimbursements decline again in Germany
Public health insurance reimbursements for cannabis in Germany have fallen for the second straight quarter. Unless this drop is being offset by an increase in private prescriptions, it means that total sales of medical cannabis in Germany – Europ…
Uruguay completes another large export of high-THC flower to Portugal
Uruguay-based Fotmer completed another large export of high-THC flower to Portugal at the end of November, according to Uruguayan customs records viewed by Marijuana Business Daily. The company declared two exports, each with a value of almost $1.3 mil…
Switzerland moves toward broader medical cannabis access
The Swiss National Council – the country’s lower house – this week approved a Federal Council proposal to amend the narcotics law and make it easier for patients to access medical cannabis. The amendment still needs the approval of th…
Mexico hits snooze on cannabis legalization until next spring
The Supreme Court of Mexico has again extended the deadline for legislators to comply with a mandate to legalize adult-use cannabis. Now Congress can legislate on this matter until the end of the next ordinary session period, which starts in February 2…
First prescriptions of high-THC products imminent in Peru
Khiron Life Sciences – a Toronto-based company with its main operations in Colombia – announced Thursday that it successfully completed the first export from Colombia of high THC medical cannabis products. They were imported into Peru. The company expe…
Brazil postpones evaluation of CBD formulation for medical coverage
A government evaluation to include a specific CBD formulation in Brazil’s Public Health System (SUS) has been postponed. The National Committee for Health Technology Incorporation (Conitec), a government agency, had been scheduled to take up the …
Mexican Congress delays cannabis bill debate, pushing approval into 2021
The Mexican lower house decided Tuesday to delay debating the cannabis legalization bill until the next legislative period, which starts in February 2021, local newspapers reported. Lawmakers say they need more time to study the bill. The delays should…